期刊文献+

肿瘤坏死因子受体选择性拮抗剂的研究进展 被引量:5

Research advance of selective inhibitor of tumornecrosis factor receptor
下载PDF
导出
摘要 肿瘤坏死因子(TNF)信号通路是很有价值的治疗靶标,抗TNF药物已成功治疗自身免疫和炎症疾病,但传统的抗TNF药物完全封闭TNF信号通路,导致影响自身的免疫调节和监视功能而增加感染、致癌的风险和产生新的自身免疫疾病。选择性抑制sTNF/TNFR1而保留mTNF/TNFR2传导的信号能减少副作用而不降低治疗效果。该文探讨了选择性抑制TNFR1介导的信号通路对治疗TNF相关疾病的意义,分析TNF识别并激活肿瘤坏死因子受体(TNFR)的作用机制,可能会为设计新药提供新的思路。 TNF signaling pathway was a valuable target ,and anti-TNF drugs were successfully used to treat autoim-mune and inflammatory diseases .But this therapy abrogate some beneficial TNF signaling ,leading to increased risk of infection and malignancy ,and the onset of new auto-immune diseases .Inhibiting the soluble TNF/TNFR1 axis while saving the benefi-cial transmembrane TNF/TNFR2 signaling untouched was a new approach .Because it inhibited the pathological effects of TNF and reduced the side effects ,and opened the way for the treatment of other diseases in which TNFR2 inhibition was detrimen-tal .The significance of the selective inhibition of TNFR1-mediated signaling pathways for TNF-related diseases was discussed and the mechanism of TNF identification TNFR was clarified ,which might provide new ideas for the design of new drugs .
出处 《药学实践杂志》 CAS 2015年第5期392-395,共4页 Journal of Pharmaceutical Practice
基金 国家自然科学基金(30500093) 国家科技部"重大新药创制"专项(2009ZX09103-690) 上海市科委重点项目(04JC14002) 军队"十一五"计划(06Q042) 上海市高校优秀青年教师科研专项基金(ejd09011)
关键词 肿瘤坏死因子受体 选择性拮抗 药物靶点 TNFR selective inhibition drug target
  • 相关文献

参考文献21

  • 1Apostolaki M, Armaka M, Victoratos P,etal. Cellular mech- anisms of TNF function in models of inflammation and auto- immunity[-J]. Curt Dir Autoimmun, 2010,11 (2) : 1-26. 被引量:1
  • 2Mukai Y,Nakamura T, Yoshikawa M,et al. Solution of the structure of the TNF-TNFR2 complex[-J]. Sci Signal, 2010,3 (148): 1-10. 被引量:1
  • 3Hehlgans T, Pfeffer K. The intriguing biology of the tumou- necrosis factor/tumour necrosis factor receptor superfamily players, rules and the games[J ]. Immunology, 2005,115 ( 1 ) : 1-20. 被引量:1
  • 4Mcllwain DR, Lang PA, Maretzky T,et al. IRhom2 regulation of TACE controls TNF-mediated protection against listeria and responses to LPS[J]. Science,2012,335(6065) :229-232. 被引量:1
  • 5Chen X, Wu X, Zhou Q,et al. TNFR2 is critical for the sta- bilization of the CD4-FFoxp3-F Regulatory T cell phenotype in the inflammatory environmentl[J]. J Immuno,2013, 190 (3) : 1076-1084. 被引量:1
  • 6Faustman D, Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases[J]. Nat Rev Drug Discov, 2010, 9 (6) :482-493. 被引量:1
  • 7Magis C, van der Sloot AM, Serrano L,et al. An improved understanding of TNFL/TNFR interactions using structure- based classi cations [J]. Trends Biochem Sci, 2012, 37 (9) : 353-363. 被引量:1
  • 8Dixon,Hyrich KL, Watson KD, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy, results from the British Society for Rheu- matology Biologics Register (BSRBR)[J]. Ann Rheum Dis,2010,69(3):522-528. 被引量:1
  • 9Takeuehi T, Tatsuki Y, NogamiY, et al. Post marketing surveillance of the safety profile of infliximab in 5 000 Japa- nese patients with rheumatoid arthritis[-J]. Ann Rheum Dis, 2008, 67(2) :189-194. 被引量:1
  • 10Tang W, Lu Y, Tian QY,etal. The growth factor progranu- lin binds to TNF receptors and is therapeutic against inflam- matory arthritis in miee[J]. Science, 2011, 332(6028) : 478- 484. 被引量:1

二级参考文献8

  • 1何亚萍,李卓娅,姜晓丹,冯玮,徐勇,熊平.TNF受体封闭肽对大鼠佐剂性关节炎的影响[J].药学学报,2003,38(12):889-892. 被引量:3
  • 2Bemelans M H A, van Tits L J, Buurman W A. Tumof necrosis factor: function, release and clearance[ J]. Crit Reviews Immunol, 1996; 16: 1- 11. 被引量:1
  • 3Yanofasky S D, Baldwin D N, Butler J H et al. High affinity type I interleukin I receptor antagonists discovered by screening recombinant peptide libraries[J]. Proc Natl Acad Sci USA, 1996;93(14) :7381-861. 被引量:1
  • 4Triantaphyllopoulos K, Croxford J, Baker D et al. Cloning and espression of murine IFN beta and a TNF antagonist for gene therapy of esperimental allergic encephalomyelitis[ J ]. Gene Ther, 1998; 5: 253-263. 被引量:1
  • 5Peppel K, Crawford D, Beutler B. A tumor necrosis factor (TNF) receptor IgG heavy chain chemeric protein as a bivalent a antagonist of TNF activity[J]. U Exp Med, 1991 ; 174:1483-1489. 被引量:1
  • 6Haak-Frendscho M, Marsters S A, Mordenti J et al. Inhibition of TNF by a TNF receptor immunoadhesin: chomparison to an anti-TNF monoclonal antibody[ J] .J Immurtol, 1994; 152:1347-1353. 被引量:1
  • 7李越希,李朝,陶开华,贾向红,程度胜,黄培堂.TPO模拟肽与人IgG1 Fc片段的融合表达及其生物学特性研究[J].生物工程学报,2002,18(4):424-430. 被引量:6
  • 8何亚萍,尹丙姣,李卓娅,徐勇,姜小丹,冯玮,熊平.TNF受体封闭肽对大鼠腹腔巨噬细胞功能的影响[J].中国免疫学杂志,2003,19(6):385-387. 被引量:6

共引文献2

同被引文献38

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部